rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
149	Seborrheic keratosis	C0022603	8	27	4.36803926362e-11	3.5333175243063796e-05	HRAS,FGF3,PIK3R1,FGFR2,FGFR3,NRAS,KRAS,PIK3CA
156	Gastrointestinal stromal tumor	C0238198	20	340	3.81380704795e-10	3.699312307327484e-05	ERBB2,ABCG2,FGF3,FGF2,FGFR1,HBEGF,FGFR2,FGFR3,NRAS,KRAS,ABL1,EREG,PIK3CA,KIT,ABCB1,SLIT2,FGFR4,SRC,CYP3A4,KITLG
157	Somatic mutation	C0544886	10	72	5.43556755161e-10	3.7230258477590705e-05	HRAS,ERBB2,FGFR2,FGFR3,NRAS,KRAS,PIK3CA,KIT,PTPN11,JAK2
158	Genitourinary neoplasm	C0042065	13	141	8.34730173871e-10	3.746739388190657e-05	HRAS,ABCG2,FGFR2,FGFR3,NRAS,KRAS,PIK3CA,KIT,ABCB1,CYP2C8,SRC,CYP3A4,UGT1A1
161	Juvenile myelomonocytic leukemia	C0349639	11	116	8.27350299382e-09	3.8178800094854166e-05	PIK3R1,SOS1,PIK3R2,NRAS,KRAS,ABL1,PIK3CA,KIT,PTPN11,JAK2,SRC
162	Papillary adenocarcinoma	C0001420	6	26	1.19537599819e-08	3.841593549917002e-05	HRAS,ERBB2,NRAS,CYP2D6,KRAS,PIK3CA
169	Telecanthus	C0423113	10	99	1.64085790511e-08	4.007588332938108e-05	HRAS,PIK3R1,FGFR1,FGFR2,FGFR3,PIK3R2,NRAS,KRAS,FGF10,KITLG
170	Chronic myeloid leukemia	C0023473	29	822	1.88926706501e-08	4.0313018733696945e-05	HRAS,MGST2,CDC42,ERBB2,ABCG2,HGF,SOS1,FGF2,CYP2B6,FGFR1,FGFR3,STAT1,NRAS,LYN,CYP2D6,KRAS,ABL1,PIK3CA,KIT,PTPN11,ABCB1,JAK2,FGFR4,SRC,GRB7,CYP3A4,GRB2,KITLG,UGT1A1
171	Drug Allergy	C0013182	9	79	2.08927104506e-08	4.055015413801281e-05	UGT1A8,UGT1A9,CYP2D6,CYP2C9,ABCB1,CYP2C8,UGT1A7,CYP3A4,UGT1A1
173	Rhabdoid Tumor of the Kidney	C0854917	10	105	3.05573643056e-08	4.1024424946644536e-05	HRAS,CDC42,ERBB2,NRG1,HGF,FGFR3,KRAS,PIK3CA,KIT,SRC
174	Neoplasm of the skin	C0037286	20	438	3.24457026801e-08	4.12615603509604e-05	HRAS,ERBB2,PIK3R1,HGF,SOS1,CYP2B6,FGFR1,FGFR2,FGFR3,STAT1,NRAS,CYP2D6,KRAS,PIK3CA,KIT,ABCB1,SLIT2,FGFR4,CYP3A4,ERBB4
175	Ovarian Neoplasms	C0919267	31	942	3.2947582107e-08	4.149869575527626e-05	HRAS,ERBB2,ABCG2,NRG1,PIK3R1,HGF,FGF7,SOS1,FGF8,FGF2,CYP2B6,HBEGF,FGFR2,NRAS,CYP2C9,KRAS,GPC1,EREG,PIK3CA,KIT,ABCB1,JAK2,FGFR4,SRC,CYP3A4,GRB2,FGF1,KITLG,UGT1A1,FGF16,ERBB4
176	Neutropenia	C0027947	15	255	3.87529557333e-08	4.1735831159592126e-05	CDC42,ABCG2,PIK3R1,UGT1A9,STAT1,NRAS,CYP2C9,KRAS,ABCB1,CYP2C8,UGT1A7,JAK2,CYP3A4,UGT1A,UGT1A1
177	gliosarcoma	C0206726	8	64	4.20296312198e-08	4.197296656390799e-05	HGF,SOS1,CYP2B6,FGFR1,FGFR3,KIT,CYP3A4,KITLG
178	Leukopenia	C0023530	16	301	6.73049881383e-08	4.2210101968223854e-05	HRAS,CDC42,UGT1A8,ABCG2,UGT1A9,CYP2B6,STAT1,UGT1A6,KRAS,ABCB1,CYP2C8,UGT1A7,JAK2,CYP3A4,UGT1A,UGT1A1
179	Mammary Tumorigenesis	C1512981	11	141	7.44304265998e-08	4.2447237372539724e-05	HRAS,CDC42,ERBB2,FGF3,FGFR1,NRAS,KRAS,EREG,PIK3CA,JAK2,GRB2
190	Chronic myelomonocytic leukemia	C0023480	10	115	7.89127579948e-08	4.505572682001423e-05	HRAS,FGFR1,NRAS,KRAS,ABL1,KIT,PTPN11,JAK2,GRB2,KITLG
191	Mesothelioma, malignant	C0025500	18	383	8.77337358318e-08	4.5292862224330094e-05	ABCG2,HGF,SOS1,FGF2,FGFR1,FGFR2,STAT1,LYN,KRAS,FGF18,PIK3CA,KIT,ABCB1,SRC,FYN,CYP3A4,FGF1,KITLG
193	Morphological abnormality of the inner ear	C4023381	7	51	1.00061639197e-07	4.576713303296182e-05	FGF3,SOS1,FGFR2,FGFR3,NRAS,KRAS,PTPN11
197	Synostosis involving bones of the feet	C0039093	9	98	1.67904035564e-07	4.671567465022528e-05	SOS1,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PTPN11,FGF9,FGF16
198	Hepatitis D Infection	C0011226	7	55	1.840036018e-07	4.695281005454114e-05	UGT1A8,UGT1A9,UGT1A10,UGT1A6,UGT1A7,UGT1A,UGT1A1
199	Hyperbilirubinemia	C0020433	9	99	1.84905505463e-07	4.718994545885701e-05	UGT1A8,UGT1A9,CYP2B6,UGT1A10,UGT1A6,ABCB1,UGT1A7,UGT1A,UGT1A1
200	Melanocytic nevus	C0027962	12	185	2.02874866906e-07	4.742708086317287e-05	HRAS,ERBB2,HGF,SOS1,FGF2,FGFR2,FGFR3,NRAS,KRAS,PIK3CA,KIT,PTPN11
202	Arnold-Chiari malformation	C0003803	7	56	2.1252619864e-07	4.79013516718046e-05	HRAS,FGF8,FGFR1,FGFR2,FGFR3,NRAS,PIK3CA
209	Malignant Fibrous Histiocytoma	C0334463	7	57	2.44850128395e-07	4.956129950201566e-05	HRAS,HBEGF,NRAS,EREG,ABCB1,FRS2,BTC
210	Primary malignant neoplasm of liver	C0024620	5	25	2.90426385274e-07	4.9798434906331515e-05	HGF,CYP2D6,KRAS,ABCB1,CYP3A4
211	Plagiocephaly	C0265529	6	40	2.94274587365e-07	5.003557031064738e-05	HRAS,FGFR1,FGFR2,FGFR3,NRAS,KRAS
213	Rickets	C0035579	6	41	3.51522449704e-07	5.0509841119279106e-05	HRAS,CYP2B6,FGFR1,NRAS,FGF23,KRAS
214	Urinary Bladder Neoplasms	C0005695	19	463	3.69031475378e-07	5.0746976523594976e-05	HRAS,ERBB2,FGF3,HGF,FGF2,CYP2B6,FGF4,FGFR1,FGFR2,FGFR3,STAT1,NRAS,CYP2D6,KRAS,PIK3CA,NRG4,SRC,FGF1,ERBB4
215	Acute Erythroblastic Leukemia	C0023440	12	195	3.72176667041e-07	5.098411192791084e-05	ERBB2,NRG1,FGFR1,STAT1,NRAS,ABL1,PIK3CA,KIT,ABCB1,JAK2,FGF9,ERBB4
216	Chordoma	C0008487	8	83	4.16000758396e-07	5.1221247332226704e-05	FGF2,FGFR1,FGFR2,PIK3CA,KIT,ABCB1,FGFR4,FRS2
217	Hormone receptor positive tumor	C1446409	7	61	4.19571423937e-07	5.145838273654257e-05	ERBB2,LYN,CYP2D6,ABL1,PIK3CA,JAK2,SRC
218	Febrile Neutropenia	C0746883	5	27	4.76270646477e-07	5.169551814085843e-05	UGT1A6,ABCB1,UGT1A7,UGT1A,UGT1A1
225	Enlarged thorax	C4020962	6	45	6.82632295801e-07	5.335546597106948e-05	HRAS,SOS1,FGFR3,NRAS,KRAS,PTPN11
226	Fibrous tissue neoplasm	C0206643	6	45	6.82632295801e-07	5.3592601375385346e-05	HRAS,SOS1,NRAS,KRAS,PIK3CA,KIT
228	Nevus	C0497388	11	174	7.32507770884e-07	5.406687218401707e-05	HRAS,ERBB2,SOS1,FGF2,FGFR2,FGFR3,NRAS,KRAS,PIK3CA,KIT,PTPN11
229	Gastric ulcer	C0038358	9	116	8.18044241679e-07	5.4304007588332944e-05	NRG1,HGF,SOS1,FGF2,FGFR1,FGFR2,CYP2D6,CYP2C9,CYP2C8
230	Irregular hyperpigmentation	C1860236	9	117	8.85668940964e-07	5.454114299264881e-05	HRAS,FGFR1,FGFR3,NRAS,KRAS,PIK3CA,KIT,PTPN11,KITLG
231	Melanocytic nevus of skin	C3665593	6	47	9.28025843949e-07	5.477827839696467e-05	HRAS,HGF,SOS1,FGF2,NRAS,KIT
232	Synovial sarcoma	C0039101	11	178	9.32703689727e-07	5.5015413801280534e-05	ERBB2,HGF,SOS1,FGF8,FGFR2,FGF18,PIK3CA,KIT,ABCB1,SRC,KITLG
233	Squamous cell carcinoma	C0007137	44	1855	9.51611234923e-07	5.525254920559639e-05	HRAS,CDC42,UGT1A8,ERBB2,ABCG2,FGF3,NRG1,PIK3R1,HGF,UGT1A9,FGF7,SOS1,FGF2,CYP2B6,FGF4,FGFR1,HBEGF,FGFR2,FGFR3,STAT1,NRAS,UGT1A10,UGT1A6,CYP2D6,KRAS,EREG,PIK3CA,KIT,PTPN11,ABCB1,SLIT2,UGT1A7,JAK2,FGFR4,GRB10,SRC,MGST1,FYN,CYP3A4,UGT1A,FGF9,KITLG,UGT1A1,ERBB4
234	Sporadic	C0205422	8	92	1.00626053945e-06	5.5489684609912255e-05	HRAS,FGFR1,FGFR3,NRAS,KRAS,PIK3CA,KIT,JAK2
242	Abnormal intermamillary distance	C4022412	7	69	1.10177708612e-06	5.738676784443918e-05	SOS1,FGF8,FGFR1,NRAS,KRAS,PTPN11,FGF17
243	Wide intermamillary distance	C1827524	7	69	1.10177708612e-06	5.762390324875504e-05	SOS1,FGF8,FGFR1,NRAS,KRAS,PTPN11,FGF17
244	High forehead	C0239676	9	121	1.20757085653e-06	5.7861038653070904e-05	SOS1,FGFR1,FGFR2,FGFR3,PIK3R2,NRAS,KRAS,PIK3CA,PTPN11
245	Colorectal Neoplasms	C0009404	32	1164	1.22447368178e-06	5.809817405738677e-05	HRAS,CDC42,ERBB2,ABCG2,HGF,UGT1A9,FGF7,SOS1,FGF2,FGFR1,FGFR2,FGFR3,NRAS,UGT1A6,CYP2D6,CYP2C9,KRAS,ABL1,PIK3CA,KIT,ROBO1,ABCB1,CYP2C8,SLIT2,UGT1A7,SRC,CYP3A4,KITLG,UGT1A1,YES1,ERBB4,FGF20
246	Neurofibromatosis, type 1, 162200 (3)	C0027831	10	152	1.32761419447e-06	5.833530946170263e-05	HRAS,CDC42,ERBB2,HGF,KRAS,PIK3CA,KIT,PTPN11,JAK2,KITLG
263	Renal agenesis	C0542519	8	97	1.57587321714e-06	6.236661133507233e-05	FGF8,FGFR1,FGFR2,FGFR3,PTPN11,FGF17,FGF10,FGF20
264	Uterine leiomyosarcoma	C0280631	5	33	1.68337041151e-06	6.260374673938819e-05	ERBB2,FGFR3,NRAS,PIK3CA,SRC
265	Diarrhea 8, secretory sodium, congenital	C0011991	16	379	1.69506717318e-06	6.284088214370405e-05	UGT1A8,ERBB2,ABCG2,PIK3R1,UGT1A9,LCK,STAT1,CYP2D6,CYP2C9,KRAS,ABCB1,UGT1A7,FGFR4,CYP3A4,KLB,UGT1A1
271	Cancer of Head and Neck	C0278996	17	430	2.22875201605e-06	6.426369456959924e-05	HRAS,ERBB2,FGF2,CYP2B6,STAT1,UGT1A6,CYP2D6,CYP2C9,KRAS,PIK3CA,ROBO1,PTPN11,ABCB1,CYP2C8,UGT1A7,FGFR4,UGT1A1
272	Progressive Neoplastic Disease	C0677932	10	161	2.33448334175e-06	6.450082997391511e-05	HRAS,ERBB2,HGF,FGF4,NRAS,KRAS,ABL1,PIK3CA,ABCB1,KITLG
273	Progressive cGVHD	C3539781	10	161	2.33448334175e-06	6.473796537823097e-05	HRAS,ERBB2,HGF,FGF4,NRAS,KRAS,ABL1,PIK3CA,ABCB1,KITLG
274	Bladder carcinoma	C0699885	30	1087	2.33588210119e-06	6.497510078254684e-05	HRAS,ERBB2,FGF3,NRG1,PIK3R1,HGF,FGF7,SOS1,FGF2,CYP2B6,FGF4,FGFR1,HBEGF,FGFR2,FGFR3,STAT1,NRAS,CYP2D6,KRAS,PIK3CA,ABCB1,UGT1A7,FGFR4,SRC,CYP3A4,UGT1A,GRB2,FGF1,UGT1A1,ERBB4
276	Myelosuppression	C0854467	5	35	2.42072158108e-06	6.544937159117855e-05	ABCG2,FGF4,KIT,ABCB1,JAK2
277	Fibroma	C0016045	6	54	2.44270634608e-06	6.568650699549444e-05	HRAS,SOS1,NRAS,KRAS,PIK3CA,KIT
278	Nausea	C0027497	6	54	2.44270634608e-06	6.59236423998103e-05	HRAS,ABCG2,CYP2D6,CYP2C9,KRAS,ABCB1
279	Anaplasia	C0002793	12	231	2.50484242847e-06	6.616077780412616e-05	ERBB2,ABCG2,NRG1,HGF,SOS1,FGF2,FGFR1,EREG,PIK3CA,KIT,SRC,FGF1
280	Schwannoma	C0027809	9	132	2.6710841865e-06	6.639791320844202e-05	HRAS,ERBB2,NRG1,KRAS,EREG,PIK3CA,KIT,SLIT2,ERBB4
281	Osteomalacia	C0029442	5	36	2.87740826377e-06	6.663504861275789e-05	FGF7,FGF2,FGFR1,FGF23,CYP3A4
282	Sarcoma, Ewing	C1261473	25	829	2.98832201906e-06	6.687218401707375e-05	HRAS,ERBB2,FGF3,HGF,SOS1,FGF5,LCK,FGF2,FGF4,FGFR1,FGFR2,FGFR3,STAT1,NRAS,KRAS,ABL1,PIK3CA,KIT,PTPN11,ABCB1,FGFR4,SRC,FYN,CYP3A4,FGF1
283	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	C1853242	9	134	3.06003132455e-06	6.710931942138962e-05	CDC42,SLC35D1,SOS1,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PTPN11
285	Leukemia, Myeloid, Chronic-Phase	C0023474	7	79	3.11849240309e-06	6.758359023002135e-05	ABCG2,NRAS,ABL1,PIK3CA,ABCB1,FGFR4,KITLG
286	Endometriosis of uterus	C0341858	6	56	3.13778270611e-06	6.78207256343372e-05	HGF,SOS1,FGF2,CYP2B6,PIK3CA,FGF1
287	Radioulnar synostosis	C0158761	6	56	3.13778270611e-06	6.805786103865307e-05	SOS1,FGFR2,FGFR3,NRAS,KRAS,PTPN11
296	Choriocarcinoma	C0008497	13	279	3.9369056164e-06	7.019207967749585e-05	ERBB2,ABCG2,FGF7,FGF8,FGF2,CYP2B6,FGF4,FGFR1,FGFR2,STAT1,PIK3CA,JAK2,ERBB4
297	Synostosis of joints	C4022183	9	138	3.98773115828e-06	7.042921508181172e-05	SOS1,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PTPN11,FGF9,FGF16
298	Neoplasms, Experimental	C0027659	6	58	3.99042855592e-06	7.066635048612759e-05	HRAS,ERBB2,HGF,NRAS,KRAS,ABL1
299	Recurrent tumor	C0521158	14	320	4.08971414101e-06	7.090348589044345e-05	HRAS,CDC42,ERBB2,ABCG2,FGF3,HGF,FGF2,FGFR2,FGFR3,CYP2D6,KRAS,PIK3CA,KIT,JAK2
300	Animal Mammary Neoplasms	C0024667	50	2352	4.3547919959e-06	7.11406212947593e-05	HRAS,CDC42,ERBB2,ABCG2,FGF3,NRG1,PIK3R1,HGF,FGF7,SOS1,LCK,FGF8,FGF2,CYP2B6,FGF4,FGFR1,HBEGF,FGFR2,FGFR3,STAT1,SHC1,LYN,CYP2D6,CYP2C9,KRAS,ABL1,GPC1,EREG,PIK3CA,KIT,ROBO1,PTPN11,ABCB1,KL,CYP2C8,SLIT2,JAK2,FGFR4,SRC,GRB7,FYN,CYP3A4,GRB2,FGF10,FGF1,KITLG,UGT1A1,BTC,YES1,ERBB4
301	Hypermelanotic macule	C1842774	6	59	4.48429390343e-06	7.137775669907518e-05	FGFR3,KRAS,PIK3CA,KIT,PTPN11,KITLG
305	Adverse drug events and drug allergies	C0041755	6	60	5.02792022905e-06	7.232629831633863e-05	ABCG2,CYP2D6,CYP2C9,ABCB1,KITLG,UGT1A1
307	Malignant Glioma	C0555198	16	412	5.17500778918e-06	7.280056912497037e-05	ERBB2,PIK3R1,HGF,SOS1,FGF2,CYP2B6,HBEGF,FGFR2,STAT1,PIK3R2,EREG,PIK3CA,KIT,ROBO1,SLIT2,FGFR4
308	Pancreatic Neoplasms	C0030297	23	750	5.2025889925e-06	7.303770452928623e-05	HRAS,ERBB2,ABCG2,NRG1,PIK3R1,HGF,FGF7,FGF2,CYP2B6,FGFR2,FGFR3,NRAS,KRAS,GPC1,PIK3CA,KIT,PTPN11,ABCB1,SLIT2,JAK2,SRC,FGF10,ERBB4
309	Recurrent fractures	C0016655	8	112	5.2282777262e-06	7.32748399336021e-05	HRAS,FGF8,FGFR1,FGFR2,NRAS,FGF23,KRAS,FGF17
310	Genital neoplasm	C0679347	7	85	5.42600194597e-06	7.351197533791796e-05	FGFR2,FGFR3,NRAS,KRAS,PIK3CA,KIT,SRC
311	Neurofibromatoses	C0162678	5	40	5.45951206887e-06	7.374911074223381e-05	CDC42,ERBB2,KRAS,KIT,PTPN11
329	Head and Neck Neoplasms	C0018671	14	333	6.6082040886e-06	7.801754801991938e-05	ERBB2,ABCG2,FGF5,FGF2,CYP2D6,CYP2C9,KRAS,ROBO1,ABCB1,CYP2C8,UGT1A7,FGFR4,CYP3A4,FGF9
330	Benign Prostatic Hyperplasia	C1704272	16	423	7.31343582305e-06	7.825468342423524e-05	ERBB2,FGF7,FGF2,FGFR1,FGFR2,FGFR3,FGF23,KRAS,KIT,ABCB1,JAK2,FGFR4,FYN,CYP3A4,FGF17,FGF9
331	Premature skin wrinkling	C0037301	5	42	7.32147143701e-06	7.849181882855111e-05	PIK3R1,FGFR2,FGFR3,KRAS,PTPN11
332	Chemical Carcinogenesis	C0596321	5	42	7.32147143701e-06	7.872895423286697e-05	HRAS,CYP2B6,CYP2D6,KRAS,SLIT2
333	Carcinosarcoma	C0007140	5	42	7.32147143701e-06	7.896608963718284e-05	ERBB2,FGFR2,KRAS,PIK3CA,KIT
342	Hepatic cancer metastatic	C0345904	20	613	7.40899709106e-06	8.110030827602562e-05	HRAS,UGT1A8,PIK3R1,HGF,FGF19,UGT1A9,CYP2B6,PIK3R2,NRAS,UGT1A10,CYP2D6,CYP2C9,KRAS,PIK3CA,ROBO1,ABCB1,UGT1A7,CYP3A4,KITLG,UGT1A1
343	Neoplasms, Germ Cell and Embryonal	C0027658	6	64	7.78211251784e-06	8.133744368034147e-05	CYP2B6,CYP2C9,KRAS,KIT,CYP3A4,KITLG
344	Refractory cancer	C0677936	6	64	7.78211251784e-06	8.157457908465734e-05	ERBB2,KRAS,ABL1,PIK3CA,KIT,ABCB1
345	Generalized joint laxity	C1836308	4	25	7.81526047144e-06	8.18117144889732e-05	FGF8,FGFR1,FGFR3,FGF17
346	Hepatocarcinogenesis	C1512409	17	471	7.83701082052e-06	8.204884989328907e-05	HRAS,ERBB2,HGF,FGF19,SOS1,CYP2B6,FGFR1,HBEGF,NRAS,PIK3CA,PTPN11,KL,UGT1A7,FGFR4,CYP3A4,UGT1A,UGT1A1
347	Deafness, autosomal recessive 44	C0011053	12	257	8.00403314005e-06	8.228598529760493e-05	UGT1A8,ABCG2,FGF3,HGF,UGT1A9,SOS1,UGT1A10,UGT1A6,PTPN11,UGT1A7,KITLG,UGT1A1
348	Brain neoplasm	C0006118	21	667	8.12391344351e-06	8.25231207019208e-05	HRAS,ERBB2,ABCG2,HGF,FGF5,FGF2,CYP2B6,FGFR1,STAT1,NRAS,CYP2D6,CYP2C9,KRAS,PIK3CA,KIT,ABCB1,SLIT2,JAK2,SRC,FGF9,ERBB4
349	Hearing Loss, Partial	C0018772	9	150	8.37900177653e-06	8.276025610623667e-05	UGT1A8,ABCG2,UGT1A9,SOS1,UGT1A10,UGT1A6,PTPN11,UGT1A7,UGT1A1
350	Solid tumour	C0280100	23	772	8.42654993849e-06	8.299739151055253e-05	HRAS,ERBB2,ABCG2,HGF,SOS1,FGF2,CYP2B6,FGFR1,FGFR3,KRAS,ABL1,PIK3CA,KIT,ROBO1,PTPN11,ABCB1,SLIT2,JAK2,FGFR4,SRC,GRB7,UGT1A1,ERBB4
351	Ovarian epithelial cancer stage III	C0280220	5	43	8.42859001549e-06	8.32345269148684e-05	ERBB2,ABCG2,HGF,PIK3CA,ABCB1
352	Ameloblastoma	C0002448	6	65	8.637889235e-06	8.347166231918425e-05	FGF3,FGF7,FGFR1,FGFR2,GPC1,FGF10
353	Abnormality of the radius	C4025675	9	151	8.88502174701e-06	8.370879772350012e-05	SOS1,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PTPN11,FGF9,FGF10
354	Hypereosinophilic syndrome	C1540912	4	26	9.58702348131e-06	8.394593312781598e-05	FGFR1,ABL1,KIT,JAK2
355	Inappropriate ADH Syndrome	C1332347	4	26	9.58702348131e-06	8.418306853213185e-05	ERBB2,FGF3,PIK3CA,KL
356	Endometrial carcinoma	C0476089	22	726	9.66216496689e-06	8.442020393644771e-05	HRAS,ERBB2,FGF3,PIK3R1,HGF,FGF7,FGF2,CYP2B6,FGFR2,PIK3R2,KRAS,PIK3CA,KIT,ABCB1,FGFR4,SRC,CYP3A4,UGT1A,FGF9,FGF10,KITLG,UGT1A1
357	Pulmonary artery stenosis	C0238397	5	44	9.66754624054e-06	8.465733934076358e-05	SOS1,FGFR1,NRAS,KRAS,PTPN11
358	Cleft Lip	C0008924	14	345	1.00747369876e-05	8.489447474507945e-05	ERBB2,FGF3,FGF7,FGF8,FGF2,FGFR1,FGFR2,FGFR3,KRAS,FGF18,FGF9,FGF10,FGF1,FGF20
363	Lymphedema, primary, with myelodysplasia	C0024236	7	93	1.062270177e-05	8.608015176665876e-05	CDC42,HGF,SLC35D1,SOS1,NRAS,KRAS,PTPN11
364	Acute myocardial ischemia	C0151744	17	484	1.13219662861e-05	8.631728717097463e-05	ERBB2,HGF,FGF2,CYP2B6,FGF4,UGT1A6,CYP2D6,CYP2C9,PIK3CA,KIT,ABCB1,KL,JAK2,CYP3A4,FGF1,KITLG,UGT1A1
365	Gallbladder adenocarcinoma	C0279651	4	27	1.16576076442e-05	8.655442257529049e-05	ERBB2,ABCG2,KRAS,JAK2
366	Hypertelorism	C0020534	16	439	1.18419720314e-05	8.679155797960636e-05	HRAS,FGF3,PIK3R1,SOS1,FGF8,FGFR1,FGFR2,FGFR3,PIK3R2,NRAS,KRAS,PIK3CA,PTPN11,FGF17,FGF10,FGF20
367	Hyperextensible skin	C0241074	5	46	1.2587700097e-05	8.702869338392221e-05	FGFR2,FGFR3,KRAS,PTPN11,FGF10
368	Squamous cell carcinoma of lung	C0149782	10	192	1.26071524916e-05	8.72658287882381e-05	HRAS,ERBB2,LCK,FGFR1,FGFR2,FGFR3,STAT1,KRAS,PIK3CA,ABCB1
369	Esophageal carcinoma	C0152018	19	585	1.26298880895e-05	8.750296419255395e-05	HRAS,UGT1A8,ERBB2,FGF3,HGF,FGF2,FGF4,FGFR2,STAT1,CYP2C9,KRAS,ABL1,PIK3CA,ABCB1,JAK2,GRB7,UGT1A,UGT1A1,ERBB4
370	Neoplasm by histology	C4023186	10	193	1.3237096315e-05	8.774009959686982e-05	HRAS,ERBB2,SOS1,FGFR3,NRAS,KRAS,PIK3CA,KIT,PTPN11,SRC
371	Acute kidney injury	C0022660	12	270	1.35517317473e-05	8.797723500118568e-05	HGF,UGT1A9,SOS1,HBEGF,FGF23,CYP2D6,CYP2C9,ABL1,ABCB1,KL,CYP3A4,UGT1A1
385	Idiopathic hypereosinophilic syndrome	C0206141	4	28	1.40613666721e-05	9.129713066160777e-05	FGFR1,ABL1,KIT,JAK2
386	Hyposmia	C2364082	4	28	1.40613666721e-05	9.153426606592364e-05	FGF8,FGFR1,PTPN11,FGF17
387	Breast cancer recurrent	C0278493	4	28	1.40613666721e-05	9.17714014702395e-05	ERBB2,FGFR1,FGFR4,FGF17
388	Thickened nuchal skin fold	C1836940	5	47	1.42940181859e-05	9.200853687455538e-05	HRAS,SOS1,NRAS,KRAS,PTPN11
391	Downslanted palpebral fissures	C0423110	11	235	1.62610545928e-05	9.271994308750297e-05	HRAS,FGF3,SOS1,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PIK3CA,PTPN11,FGF10
392	Cystic hygroma	C0206620	4	29	1.68345533746e-05	9.295707849181884e-05	SOS1,NRAS,KRAS,PTPN11
393	Excessive wrinkled skin	C4024890	4	29	1.68345533746e-05	9.31942138961347e-05	FGFR2,FGFR3,KRAS,PTPN11
394	Abnormality of the pulmonary artery	C0009681	6	72	1.70882461467e-05	9.343134930045056e-05	SOS1,FGFR1,NRAS,KRAS,PTPN11,KITLG
395	Abnormality of forearm bone	C4022452	9	163	1.7347411199e-05	9.366848470476642e-05	SOS1,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PTPN11,FGF9,FGF10
396	Neoplasm Recurrence, Local	C0027643	12	277	1.77573320748e-05	9.390562010908228e-05	HRAS,ERBB2,ABCG2,FGF5,FGF2,FGFR3,NRAS,CYP2D6,KRAS,PIK3CA,KIT,FGF9
397	Abnormally lax or hyperextensible skin	C1537528	7	100	1.81330569772e-05	9.414275551339815e-05	HRAS,FGFR2,FGFR3,KRAS,PTPN11,FGF10,FGF20
398	Precancerous Conditions	C0032927	16	455	1.8730961776e-05	9.437989091771402e-05	HRAS,ERBB2,HGF,UGT1A9,SOS1,FGF2,FGFR3,NRAS,KRAS,ABL1,PIK3CA,SLIT2,FGFR4,UGT1A,UGT1A1,YES1
399	Hodgkin Disease	C0019829	15	409	1.89197606145e-05	9.461702632202989e-05	ERBB2,PIK3R1,HGF,SOS1,FGF2,FGFR2,UGT1A6,CYP2C9,KRAS,PIK3CA,PTPN11,ABCB1,KL,JAK2,UGT1A1
400	Abnormality of the forearm	C4025666	9	165	1.92812795687e-05	9.485416172634575e-05	SOS1,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PTPN11,FGF9,FGF10
401	Myeloproliferative disorder (2)	C1292778	9	165	1.92812795687e-05	9.509129713066162e-05	FGFR1,NRAS,ABL1,PIK3CA,KIT,PTPN11,ABCB1,JAK2,FGFR4
409	Cubitus valgus	C0158465	4	30	2.00157245622e-05	9.698838036518852e-05	SOS1,KRAS,PTPN11,FGF9
410	Aplasia/Hypoplasia of the abdominal wall musculature	C4023909	4	30	2.00157245622e-05	9.72255157695044e-05	SOS1,NRAS,KRAS,PTPN11
411	Obstructive sleep apnea	C0520679	9	166	2.03158084409e-05	9.746265117382025e-05	HRAS,NRG1,HGF,FGFR1,FGFR2,FGFR3,CYP2D6,EREG,ABCB1
412	Squamous cell carcinoma of the skin	C0553723	9	166	2.03158084409e-05	9.769978657813612e-05	HRAS,ERBB2,HBEGF,FGFR2,FGFR3,PIK3CA,SLIT2,SRC,FGF10
413	Lung Neoplasms	C0024121	29	1155	2.08218528779e-05	9.793692198245198e-05	HRAS,CDC42,ERBB2,ABCG2,NRG1,HGF,CYP2B6,FGFR1,FGFR2,NRAS,CYP2D6,CYP2C9,KRAS,ABL1,EREG,PIK3CA,KIT,ROBO1,ABCB1,JAK2,FGFR4,MGST1,GRB7,CYP3A4,FGF9,FGF1,KITLG,UGT1A1,ERBB4
414	Abnormal localization of kidney	C4020968	7	102	2.09575988946e-05	9.817405738676785e-05	HRAS,FGFR1,FGFR2,PIK3R2,NRAS,KRAS,PTPN11
415	Triple Negative Breast Neoplasms	C3539878	16	461	2.21188872812e-05	9.84111927910837e-05	ERBB2,ABCG2,HGF,FGF2,FGFR1,HBEGF,FGFR2,STAT1,KRAS,ABL1,PIK3CA,KIT,PTPN11,ABCB1,SRC,GRB7
416	Neoplasm Invasiveness	C0027626	9	168	2.25284765472e-05	9.864832819539958e-05	HRAS,NRG1,HGF,FGFR3,NRAS,KRAS,PIK3CA,SRC,FGF16
417	Uterine Cancer	C0153567	5	51	2.30849612464e-05	9.888546359971543e-05	ERBB2,NRAS,KRAS,PIK3CA,ABCB1
418	T-cell acute lymphoblastic leukemias	C1961099	14	371	2.35858481247e-05	9.912259900403132e-05	HRAS,ABCG2,LCK,FGFR1,STAT1,NRAS,ABL1,PIK3CA,KIT,PTPN11,ABCB1,JAK2,FGFR4,SRC
419	Hypophosphatemic rickets	C3536983	4	31	2.36455839373e-05	9.935973440834717e-05	HRAS,NRAS,FGF23,KRAS
420	Chronic leukemia	C1279296	4	31	2.36455839373e-05	9.959686981266303e-05	ABL1,KIT,ABCB1,JAK2
421	Neuroectodermal neoplasm	C0206093	7	104	2.41423116857e-05	9.98340052169789e-05	HRAS,ERBB2,HGF,KRAS,PIK3CA,PTPN11,SRC
422	Myeloproliferative Disorders	C0027022	11	245	2.45586774722e-05	0.00010007114062129476	FGF2,FGFR1,NRAS,ABL1,PIK3CA,KIT,PTPN11,ABCB1,JAK2,FGFR4,KITLG
423	Squamous cell carcinoma of the head and neck	C1168401	23	825	2.48442468256e-05	0.00010030827602561063	HRAS,CDC42,ERBB2,ABCG2,FGF3,HGF,SOS1,LCK,FGF2,FGFR1,HBEGF,FGFR2,FGFR3,STAT1,CYP2D6,CYP2C9,KRAS,PIK3CA,ABCB1,JAK2,FGFR4,MGST1,ERBB4
426	Joint hypermobility	C0086437	11	247	2.66012953688e-05	0.00010101968223855821	HRAS,PIK3R1,SOS1,FGF8,FGFR1,FGFR3,NRAS,KRAS,PIK3CA,PTPN11,FGF17
432	Philadelphia chromosome positive	C0856536	4	32	2.77669397718e-05	0.00010244249466445341	ABL1,PIK3CA,JAK2,SRC
433	Carcinoma of colon	C0699790	40	1856	2.8500533254e-05	0.00010267963006876926	HRAS,CDC42,ERBB2,ABCG2,FGF3,PIK3R1,HGF,FGF19,UGT1A9,FGF7,SOS1,LCK,FGF2,HBEGF,FGFR2,FGFR3,STAT1,PIK3R2,NRAS,UGT1A6,CYP2D6,CYP2C9,KRAS,FGF18,PIK3CA,KIT,PTPN11,ABCB1,KL,UGT1A7,JAK2,FGFR4,SRC,CYP3A4,UGT1A,FGF9,FGF1,UGT1A1,YES1,ERBB4
434	Neoplasm of the nervous system	C0027766	8	139	2.99184750182e-05	0.00010291676547308513	HRAS,ERBB2,FGFR1,NRAS,KRAS,PIK3CA,KIT,PTPN11
435	Malignant gastrointestinal tract tumors	C0685938	11	251	3.11339368915e-05	0.00010315390087740099	ERBB2,CYP2B6,FGFR3,NRAS,KRAS,PIK3CA,KIT,ABCB1,UGT1A7,SRC,CYP3A4
436	Rhabdomyosarcoma alveolar	C0035412	14	381	3.20348712353e-05	0.00010339103628171686	HRAS,CDC42,ERBB2,HGF,SOS1,FGFR1,NRAS,KRAS,PIK3CA,KIT,PTPN11,ABCB1,FGFR4,KITLG
437	Nerve Sheath Tumors	C0206727	5	54	3.2180945121e-05	0.00010362817168603272	ERBB2,NRG1,HGF,KRAS,KIT
438	Germ cell neoplasia	C0205851	11	252	3.23667486881e-05	0.0001038653070903486	HRAS,ERBB2,FGF3,FGF4,FGFR2,FGFR3,NRAS,KRAS,PIK3CA,KIT,KITLG
439	Thymoma	C0040100	9	176	3.35725169839e-05	0.00010410244249466446	HRAS,LCK,STAT1,NRAS,FGF23,KRAS,ABL1,PIK3CA,KIT
445	Intrahepatic Cholangiocarcinoma	C0345905	7	109	3.3920810158e-05	0.00010552525492055964	ERBB2,HGF,FGFR2,KRAS,ROBO1,SLIT2,GRB2
446	Fibrosarcoma	C0016057	11	254	3.49601447699e-05	0.0001057623903248755	HRAS,ERBB2,ABCG2,HGF,FGF2,CYP2B6,STAT1,NRAS,PIK3CA,ABCB1,KITLG
447	Hyperpigmentation of the skin	C0162834	9	177	3.52337400326e-05	0.00010599952572919137	HRAS,FGFR1,FGFR3,NRAS,KRAS,PIK3CA,KIT,PTPN11,KITLG
448	Malignant tumor of urinary bladder	C0005684	32	1371	3.61969219609e-05	0.00010623666113350724	HRAS,UGT1A8,ERBB2,FGF3,NRG1,PIK3R1,HGF,UGT1A9,SOS1,FGF2,CYP2B6,FGF4,FGFR1,HBEGF,FGFR2,FGFR3,STAT1,NRAS,UGT1A10,CYP2D6,CYP2C9,KRAS,PIK3CA,ABCB1,UGT1A7,FGFR4,CYP3A4,UGT1A,GRB2,FGF1,UGT1A1,ERBB4
449	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	43	2073	3.66643469473e-05	0.00010647379653782311	HRAS,CDC42,ERBB2,ABCG2,FGF3,NRG1,PIK3R1,HGF,FGF7,SOS1,FGF2,CYP2B6,FGF4,FGFR1,HBEGF,FGFR2,FGFR3,STAT1,PIK3R2,NRAS,UGT1A6,CYP2C9,KRAS,EREG,PIK3CA,KIT,ROBO1,PTPN11,ABCB1,SLIT2,NRG4,UGT1A7,JAK2,FGFR4,SRC,GRB7,UGT1A,GRB2,FGF9,KITLG,UGT1A1,YES1,ERBB4
450	Carcinoma breast stage IV	C0278488	13	342	3.85161167119e-05	0.00010671093194213897	CDC42,ERBB2,HGF,SOS1,FGFR1,FGFR2,CYP2D6,KRAS,ABL1,PIK3CA,ABCB1,SRC,ERBB4
451	Esophageal Neoplasms	C0014859	20	686	3.90605430184e-05	0.00010694806734645484	UGT1A8,ERBB2,HGF,FGF7,FGF2,FGF4,STAT1,CYP2C9,KRAS,ABL1,PIK3CA,KIT,ABCB1,CYP2C8,JAK2,GRB7,CYP3A4,UGT1A,UGT1A1,ERBB4
452	Abnormality of the helix	C1856660	6	82	4.00643671774e-05	0.00010718520275077069	SOS1,FGFR2,FGFR3,NRAS,KRAS,PTPN11
453	Neoplasm of the central nervous system	C0085136	8	145	4.17297946897e-05	0.00010742233815508656	ERBB2,HGF,SOS1,FGFR1,NRAS,KRAS,PIK3CA,PTPN11
457	Small cell lung cancer	C0149925	19	638	4.3074070226e-05	0.00010837087977235	HRAS,ERBB2,ABCG2,HGF,SOS1,FGF2,FGFR1,CYP2D6,PIK3CA,KIT,ROBO1,ABCB1,KL,SLIT2,JAK2,SRC,CYP3A4,FGF1,UGT1A1
458	 Gastric cancer, somatic, 137215 (3)	C1860985	4	35	4.35403490143e-05	0.00010860801517666589	ERBB2,FGFR2,KRAS,PIK3CA
459	Asymmetric growth	C4022025	4	35	4.35403490143e-05	0.00010884515058098174	HRAS,NRAS,KRAS,PIK3CA
460	Chronic eosinophilic leukemia	C0346421	4	35	4.35403490143e-05	0.00010908228598529761	FGFR1,ABL1,KIT,JAK2
461	Abnormal platelet function	C0855740	4	35	4.35403490143e-05	0.00010931942138961347	SOS1,NRAS,KRAS,PTPN11
472	Fetal ultrasound soft marker	C4023366	5	58	4.85640997733e-05	0.00011192791083708798	HRAS,SOS1,NRAS,KRAS,PTPN11
473	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	41	1967	4.92468411439e-05	0.00011216504624140385	HRAS,CDC42,ERBB2,ABCG2,FGF3,NRG1,HGF,FGF7,SOS1,FGF8,FGF2,CYP2B6,FGF4,FGFR1,HBEGF,FGFR2,STAT1,PIK3R2,NRAS,CYP2D6,KRAS,ABL1,EREG,PIK3CA,KIT,ABCB1,KL,CYP2C8,SLIT2,JAK2,FGFR4,SRC,GRB7,CYP3A4,FGF1,KITLG,FRS2,UGT1A1,YES1,FGF16,ERBB4
474	Urinary tract neoplasm	C0042076	7	115	4.98244348833e-05	0.0001124021816457197	HRAS,FGFR3,NRAS,KRAS,PIK3CA,ABCB1,SRC
475	Broad hallux	C1867131	4	36	5.00988238465e-05	0.00011263931705003558	FGFR1,FGFR2,FGFR3,FGF10
476	Horseshoe kidney	C0221353	4	36	5.00988238465e-05	0.00011287645245435143	HRAS,FGFR2,NRAS,KRAS
477	Dental malocclusion	C0024636	6	85	5.05406616439e-05	0.0001131135878586673	CDC42,PIK3R1,SOS1,FGFR2,FGFR3,PTPN11
478	Renal hypoplasia/aplasia	C1857453	9	185	5.12439046664e-05	0.00011335072326298316	FGF8,FGFR1,FGFR2,FGFR3,PIK3CA,PTPN11,FGF17,FGF10,FGF20
479	Ovarian epithelial cancer	C0677886	44	2172	5.27364688105e-05	0.00011358785866729903	HRAS,CDC42,ERBB2,ABCG2,FGF3,NRG1,HGF,FGF7,SOS1,FGF8,FGF2,CYP2B6,FGF4,FGFR1,HBEGF,FGFR2,STAT1,PIK3R2,NRAS,UGT1A6,CYP2D6,CYP2C9,KRAS,ABL1,EREG,PIK3CA,KIT,ABCB1,KL,CYP2C8,SLIT2,JAK2,FGFR4,GRB10,SRC,GRB7,CYP3A4,FGF1,KITLG,FRS2,UGT1A1,YES1,FGF16,ERBB4
480	Breast adenocarcinoma	C0858252	7	116	5.29984855002e-05	0.0001138249940716149	HRAS,ERBB2,ABCG2,KRAS,PIK3CA,ABCB1,BTC
484	Abnormality of the elbow	C4021386	8	150	5.43798980704e-05	0.00011477353568887835	HRAS,SOS1,FGFR1,FGFR2,FGFR3,KRAS,PTPN11,FGF9
485	Alveolar cell carcinoma	C0007120	6	86	5.44939727429e-05	0.00011501067109319421	ERBB2,HGF,FGFR1,KRAS,PIK3CA,ABCB1
486	Chronic active hepatitis	C0520463	6	86	5.44939727429e-05	0.00011524780649751008	ERBB2,HGF,CYP2B6,STAT1,CYP2D6,KRAS
487	Influenza	C0021400	16	497	5.64884512678e-05	0.00011548494190182594	CDC42,UGT1A8,UGT1A9,FGFR1,STAT1,NRAS,UGT1A10,UGT1A6,ABL1,PIK3CA,PTPN11,ABCB1,UGT1A7,FGFR4,UGT1A,UGT1A1
488	Neoplasm of the oral cavity	C0026640	10	226	5.6550977384e-05	0.00011572207730614181	HRAS,ERBB2,NRAS,CYP2D6,CYP2C9,KRAS,PIK3CA,CYP2C8,FGFR4,CYP3A4
489	Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation	C0751690	8	151	5.72633542316e-05	0.00011595921271045768	ERBB2,NRG1,HGF,NRAS,FGF23,KRAS,KIT,ABCB1
490	Costello syndrome	C0587248	4	37	5.73952593025e-05	0.00011619634811477354	HRAS,KRAS,PIK3CA,PTPN11
491	Abnormal urine phosphate concentration	C4022828	4	37	5.73952593025e-05	0.0001164334835190894	HRAS,NRAS,FGF23,KRAS
492	Noonan syndrome with multiple lentigines	C0175704	4	37	5.73952593025e-05	0.00011667061892340526	SOS1,KRAS,PIK3CA,PTPN11
493	Hyperphosphaturia	C0268079	4	37	5.73952593025e-05	0.00011690775432772113	HRAS,NRAS,FGF23,KRAS
494	Acute postoperative pain	C0030201	4	37	5.73952593025e-05	0.00011714488973203699	SH2B2,CYP2D6,ABCB1,CYP3A4
495	Embryonal rhabdomyosarcoma	C0206656	6	87	5.86968358431e-05	0.00011738202513635286	HRAS,ERBB2,SOS1,KRAS,PIK3CA,FGFR4
496	Facial asymmetry	C1306710	6	87	5.86968358431e-05	0.00011761916054066872	HRAS,FGFR2,FGFR3,NRAS,KRAS,PIK3CA
497	Gastrointestinal Neoplasms	C0017185	11	268	5.87153467008e-05	0.00011785629594498459	HRAS,ERBB2,FGFR2,FGFR3,STAT1,NRAS,KRAS,PIK3CA,KIT,FGFR4,SRC
498	Abnormality of skeletal maturation	C4025818	11	268	5.87153467008e-05	0.00011809343134930044	HRAS,PIK3R1,SLC35D1,SOS1,FGF8,FGFR1,STAT1,NRAS,KRAS,PTPN11,FGF17
499	Neoplasm of the colon	C0009375	22	817	6.05791711302e-05	0.00011833056675361633	HRAS,ERBB2,ABCG2,PIK3R1,FGF19,UGT1A9,FGFR2,STAT1,SHC1,UGT1A6,CYP2C9,KRAS,FGF18,PIK3CA,KIT,ABCB1,JAK2,FGFR4,SRC,UGT1A,KITLG,UGT1A1
500	Broad forehead	C1849089	6	88	6.31611647515e-05	0.00011856770215793219	FGFR2,FGFR3,NRAS,KRAS,PIK3CA,FGF10
501	Pilocytic Astrocytoma	C0334583	6	88	6.31611647515e-05	0.00011880483756224806	ERBB2,FGFR1,KRAS,PIK3CA,KIT,ERBB4
502	Abnormality of the ulna	C4025662	7	119	6.35476361124e-05	0.00011904197296656391	SOS1,FGFR2,FGFR3,NRAS,KRAS,PTPN11,FGF10
503	Xerostomia	C0043352	5	61	6.47629564351e-05	0.00011927910837087977	FGFR2,FGFR3,CYP2D6,FGF10,ERBB4
504	Malignant neoplasm of stomach stage IV	C0278498	4	38	6.54851424361e-05	0.00011951624377519564	ERBB2,FGFR2,STAT1,PIK3CA
505	Invasive Carcinoma	C1334274	8	154	6.66988522851e-05	0.0001197533791795115	ERBB2,HGF,FGF8,STAT1,KRAS,PIK3CA,KL,GRB7
511	Uterine Corpus Cancer	C0153574	16	506	7.03518670314e-05	0.00012117619160540669	HRAS,ERBB2,FGF3,PIK3R1,HGF,FGF7,FGF2,FGFR2,PIK3R2,KRAS,PIK3CA,KIT,ABCB1,CYP3A4,UGT1A,UGT1A1
512	Malignant neoplasm of endometrium	C0007103	16	506	7.03518670314e-05	0.00012141332700972256	HRAS,ERBB2,FGF3,PIK3R1,HGF,FGF7,FGF2,FGFR2,PIK3R2,KRAS,PIK3CA,KIT,ABCB1,CYP3A4,UGT1A,UGT1A1
522	Delayed skeletal maturation	C0541764	10	234	7.72572782983e-05	0.00012378468105288118	HRAS,PIK3R1,SOS1,FGF8,FGFR1,STAT1,NRAS,KRAS,PTPN11,FGF17
523	Vitreoretinopathy, neovascular inflammatory, 193235 (3)	C0242852	5	63	7.77689856866e-05	0.00012402181645719705	HGF,SOS1,HBEGF,NRAS,ROBO1
524	Webbed neck	C0221217	5	63	7.77689856866e-05	0.00012425895186151292	HRAS,SOS1,NRAS,KRAS,PTPN11
525	Abnormality of the large intestine	C4025715	7	123	8.02768405739e-05	0.0001244960872658288	FGFR3,STAT1,NRAS,KRAS,PIK3CA,KIT,SRC
526	Monosomy	C0026499	8	158	8.12871405921e-05	0.00012473322267014467	ERBB2,STAT1,NRAS,ABL1,PIK3CA,KIT,ABCB1,FGF1
539	Papilloma	C0030354	9	196	8.30922366922e-05	0.00012781598292625087	HRAS,ERBB2,FGF3,PIK3R1,FGFR3,NRAS,PIK3CA,KIT,FGF10
540	Hypophosphatemia	C0085682	4	40	8.42787496126e-05	0.00012805311833056677	HRAS,NRAS,FGF23,KRAS
541	Broad toe	C1865038	4	40	8.42787496126e-05	0.0001282902537348826	FGFR1,FGFR2,FGFR3,FGF10
542	Abnormal nipple morphology	C3839073	7	124	8.49854642639e-05	0.00012852738913919848	SOS1,FGF8,FGFR1,NRAS,KRAS,PTPN11,FGF17
543	Pharyngeal Neoplasms	C0031347	5	64	8.50090131523e-05	0.00012876452454351433	ERBB2,CYP2C9,PIK3CA,CYP2C8,CYP3A4
544	Radial deviation of finger	C1836189	5	64	8.50090131523e-05	0.00012900165994783022	PIK3R1,FGFR2,FGFR3,PTPN11,FGF10
545	Lipoma	C0023798	5	65	9.27755883439e-05	0.0001292387953521461	FGFR1,KRAS,PIK3CA,KIT,ABCB1
546	Gonadal neoplasm	C0239763	5	65	9.27755883439e-05	0.00012947593075646194	FGFR2,FGFR3,KRAS,PIK3CA,KIT
547	Ovarian Failure, Premature	C0085215	9	199	9.42445835899e-05	0.0001297130661607778	SH2B2,CYP2B6,FGFR1,CYP2C9,KRAS,KIT,ABCB1,CYP3A4,KITLG
548	Neoplasm of the tongue	C0040411	4	41	9.51043107155e-05	0.00012995020156509368	HRAS,ERBB2,KRAS,PIK3CA
549	Gastrointestinal carcinoma	C0151544	4	41	9.51043107155e-05	0.00013018733696940955	FGFR3,NRAS,PIK3CA,SRC
550	Adenoid Cystic Carcinoma	C0010606	9	200	9.82330869896e-05	0.0001304244723737254	HRAS,ERBB2,FGF2,KRAS,EREG,PIK3CA,KIT,FGFR4,FGF16
555	Noonan syndrome 1	C0028326	5	66	0.000101096112488	0.00013161014939530472	HRAS,SOS1,NRAS,KRAS,PTPN11
556	Fibroadenoma of the breast	C0178421	5	66	0.000101096112488	0.0001318472847996206	ERBB2,PIK3CA,KIT,FGFR4,FGF1
557	Aplasia/Hypoplasia of the middle phalanges of the hand	C1862152	4	42	0.000106966836033	0.00013208442020393646	FGFR1,FGFR2,FGFR3,FGF10
558	Acanthosis nigricans	C0000889	4	42	0.000106966836033	0.00013232155560825233	HRAS,FGFR1,FGFR2,FGFR3
559	Angiofibromas	C0206731	4	42	0.000106966836033	0.00013255869101256817	HRAS,NRAS,KRAS,PIK3CA
572	Abnormal elasticity of skin	C4023760	7	130	0.000118300275503	0.0001356414512686744	HRAS,FGFR2,FGFR3,KRAS,PTPN11,FGF10,FGF20
579	Pulmonic stenosis	C0034089	5	68	0.000119513013982	0.00013730139909888547	HRAS,SOS1,NRAS,KRAS,PTPN11
580	Radial deviation of the hand	C0575803	5	68	0.000119513013982	0.00013753853450320134	PIK3R1,FGFR2,FGFR3,PTPN11,FGF10
581	Cholesteatoma	C0008373	4	43	0.000119932384739	0.00013777566990751718	HGF,FGF7,FGF2,EREG
582	Abnormality of the tracheobronchial system	C4021631	9	205	0.000120388918139	0.00013801280531183305	HRAS,ERBB2,PIK3R1,FGFR1,FGFR2,STAT1,KRAS,PIK3CA,FGF20
583	Hearing impairment	C1384666	25	1031	0.000121619918403	0.00013824994071614892	CDC42,UGT1A8,ABCG2,FGF3,PIK3R1,HGF,UGT1A9,SOS1,FGF8,FGFR1,FGFR2,FGFR3,STAT1,NRAS,UGT1A10,UGT1A6,KRAS,PIK3CA,KIT,PTPN11,UGT1A7,FGF17,FGF10,KITLG,UGT1A1
584	Bone fragility with contractures, arterial rupture, and deafness	C1390474	8	167	0.000124129650212	0.0001384870761204648	HRAS,FGF8,FGFR1,FGFR2,NRAS,FGF23,KRAS,FGF17
585	Macule	C0332573	6	98	0.000125071887645	0.00013872421152478066	FGFR3,KRAS,PIK3CA,KIT,PTPN11,KITLG
697	Abnormality of globe location	C4021946	17	584	0.000128342466398	0.00016528337680815747	HRAS,FGF3,PIK3R1,SOS1,FGF8,FGFR1,FGFR2,FGFR3,PIK3R2,NRAS,KRAS,PIK3CA,PTPN11,SRC,FGF17,FGF10,FGF20
698	Transitional cell carcinoma of the bladder	C0279680	7	132	0.000131550662028	0.00016552051221247334	ERBB2,FGF7,FGFR3,NRAS,KRAS,PIK3CA,SRC
699	Cystadenoma	C0010633	4	44	0.000134068930893	0.00016575764761678918	FGF7,NRAS,KRAS,PIK3CA
700	Coarse hair	C0277959	4	44	0.000134068930893	0.00016599478302110505	SOS1,NRAS,KRAS,PTPN11
701	Single tumor	C1298180	4	44	0.000134068930893	0.00016623191842542092	ERBB2,NRAS,KRAS,FGF1
702	Abnormality of the middle phalanges of the hand	C4024191	4	44	0.000134068930893	0.0001664690538297368	FGFR1,FGFR2,FGFR3,FGF10
703	Colon cancer	C0007102	36	1727	0.000135315247577	0.00016670618923405263	HRAS,CDC42,ERBB2,ABCG2,FGF3,PIK3R1,HGF,FGF19,UGT1A9,SOS1,LCK,FGF2,HBEGF,FGFR2,STAT1,NRAS,CYP2D6,CYP2C9,KRAS,FGF18,PIK3CA,KIT,PTPN11,ABCB1,KL,UGT1A7,JAK2,FGFR4,SRC,CYP3A4,UGT1A,FGF9,FGF1,UGT1A1,YES1,ERBB4
704	Gastrointestinal hemorrhage	C0017181	7	133	0.000138621250985	0.0001669433246383685	CYP2D6,CYP2C9,KRAS,PIK3CA,KIT,CYP2C8,JAK2
705	Metastatic malignant neoplasm to brain	C0220650	7	133	0.000138621250985	0.00016718046004268438	ERBB2,NRG1,FGFR1,NRAS,KRAS,PIK3CA,SLIT2
706	Abnormality of the pulmonary vasculature	C4025271	7	133	0.000138621250985	0.00016741759544700025	SOS1,FGFR1,NRAS,KRAS,PTPN11,JAK2,KITLG
707	Heart Diseases	C0018799	13	386	0.000139242710674	0.00016765473085131612	ERBB2,HGF,LCK,FGF2,FGF23,CYP2D6,CYP2C9,KRAS,PIK3CA,PTPN11,ABCB1,JAK2,FGF1
708	Giant Cell Tumors	C0017525	5	70	0.000140495886482	0.00016789186625563196	STAT1,FGF23,KRAS,KIT,SRC
715	Advanced cancer	C0877373	6	100	0.000141975478868	0.00016955181408584303	ERBB2,CYP2D6,KRAS,PIK3CA,ABCB1,CYP3A4
716	Prematurely aged appearance	C1857656	6	100	0.000141975478868	0.0001697889494901589	PIK3R1,FGFR2,FGFR3,KRAS,PTPN11,KITLG
717	Thyroid Neoplasms	C0040136	15	486	0.000144558266435	0.00017002608489447474	HRAS,ERBB2,ABCG2,NRG1,FGF2,CYP2B6,FGFR2,STAT1,NRAS,CYP2D6,KRAS,PIK3CA,KIT,FGFR4,SRC
718	Differentiated Thyroid Gland Carcinoma	C1337013	7	134	0.000146002385509	0.0001702632202987906	ERBB2,NRG1,FGF2,NRAS,PIK3CA,UGT1A,UGT1A1
719	Cholelithiasis	C0008350	8	171	0.000148486951645	0.00017050035570310648	UGT1A8,ABCG2,UGT1A9,UGT1A10,UGT1A6,UGT1A7,UGT1A,UGT1A1
720	Lymphoid leukemia	C0023448	10	252	0.00014863543676	0.00017073749110742235	LCK,NRAS,LYN,KRAS,ABL1,PTPN11,ABCB1,JAK2,CYP3A4,GRB2
721	Anosmia	C0003126	4	45	0.000149446299542	0.0001709746265117382	FGF8,FGFR1,FGFR2,FGF17
722	Benign neoplasm of the central nervous system	C0347509	4	45	0.000149446299542	0.00017121176191605406	FGFR1,NRAS,KRAS,PIK3CA
723	Bone necrosis	C0029445	4	45	0.000149446299542	0.00017144889732036993	ABCB1,KL,CYP2C8,CYP3A4
724	Redundant skin	C0581342	4	45	0.000149446299542	0.0001716860327246858	HRAS,FGFR3,KRAS,FGF20
725	Oropharyngeal disorders	C0553694	4	45	0.000149446299542	0.00017192316812900167	ERBB2,STAT1,PIK3CA,FGFR4
726	Tall stature	C0241240	6	101	0.000151095780952	0.00017216030353331752	HRAS,FGF3,FGFR3,NRAS,KRAS,PIK3CA
727	Reduced number of teeth	C4024202	8	172	0.000155162796495	0.00017239743893763342	FGF3,PIK3R1,FGF8,FGFR1,FGFR2,FGFR3,FGF17,FGF10
728	Osteopenia	C0029453	8	172	0.000155162796495	0.00017263457434194926	HRAS,FGF8,FGFR1,FGFR2,STAT1,NRAS,KRAS,FGF17
729	Cervical intraepithelial neoplasia (Cervical dysplasia)	C0206708	9	212	0.000158397648451	0.00017287170974626513	HRAS,ERBB2,FGF2,CYP2B6,FGFR2,CYP2D6,PIK3CA,ROBO1,SLIT2
730	Urothelial Carcinoma	C0007138	13	391	0.000159093855916	0.00017310884515058097	HRAS,ERBB2,PIK3R1,FGF7,FGF2,FGFR1,FGFR2,FGFR3,NRAS,KRAS,PIK3CA,ABCB1,ERBB4
731	Myelofibrosis	C0026987	6	102	0.000160684940138	0.00017334598055489684	FGF2,ABL1,PIK3CA,KIT,JAK2,SRC
739	Leiomyosarcoma	C0023269	7	136	0.000161737981284	0.00017524306378942375	FGFR3,NRAS,KRAS,PIK3CA,KIT,ABCB1,SRC
740	Basal cell carcinoma	C0007117	7	136	0.000161737981284	0.00017548019919373965	HRAS,FGFR2,NRAS,CYP2D6,KRAS,PIK3CA,FGFR4
741	Malignant tumor of esophagus	C0546837	18	650	0.000165521322909	0.0001757173345980555	UGT1A8,ERBB2,FGF3,HGF,FGF2,FGF4,CYP2C9,KRAS,ABL1,PIK3CA,ABCB1,CYP2C8,JAK2,GRB7,CYP3A4,UGT1A,UGT1A1,ERBB4
742	Female hypogonadism	C0271578	3	25	0.000166823742826	0.00017595447000237136	FGF8,FGFR1,FGF17
743	Leg Ulcer	C0023223	3	25	0.000166823742826	0.0001761916054066872	HGF,SOS1,KL
744	Lobular carcinoma in situ of breast	C0279563	3	25	0.000166823742826	0.00017642874081100308	ERBB2,FGFR2,PIK3CA
745	Saethre-Chotzen syndrome	C0175699	3	25	0.000166823742826	0.00017666587621531897	FGFR2,FGFR3,PIK3CA
746	Disorder of skeletal system	C0263661	3	25	0.000166823742826	0.00017690301161963482	FGFR1,FGFR2,FGFR3
747	Multiple Myeloma	C0026764	28	1236	0.000170117744706	0.0001771401470239507	HRAS,ERBB2,ABCG2,PIK3R1,HGF,SOS1,FGF2,CYP2B6,FGF4,FGFR1,FGFR2,FGFR3,STAT1,PIK3R2,NRAS,CYP2D6,CYP2C9,KRAS,ABL1,PIK3CA,KIT,ABCB1,CYP2C8,JAK2,FGFR4,GRB2,FGF1,KITLG
748	Endometrial adenocarcinoma	C1153706	6	103	0.000170760730047	0.00017737728242826653	ERBB2,FGF3,FGF7,FGF2,FGFR2,KRAS
749	Tumor Angiogenesis	C1519670	14	443	0.000171744719363	0.00017761441783258243	ERBB2,NRG1,HGF,FGF7,SOS1,FGF2,FGFR1,HBEGF,FGFR3,NRAS,CYP2C9,PIK3CA,SLIT2,JAK2
750	Adenoma of large intestine	C1302401	10	257	0.00017636212911	0.00017785155323689827	HRAS,ABCG2,FGF2,CYP2B6,UGT1A6,CYP2D6,CYP2C9,KRAS,ABCB1,UGT1A1
